NC-DOLE-FOOD-COMPANY
21.11.2022 15:01:36 CET | Business Wire | Press release
Dole plc (NYSE: DOLE) announced today that The American-Costa Rican Chamber of Commerce (AmCham) recognized the company’s pineapple operations in Costa Rica S.A., with the Social Responsibility in Action Award in the Employees Category for their project "Information and Wellbeing Centers."
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005224/en/
Farm Managers and Employees from Dole’s Santa Fe and Muelle Farms were present at the award ceremony, along with representatives from Dole Tropical Products and Dole’s Costa Rican subsidiary. (Photo: Business Wire)
In the designation AmCham further distinguished this project as the overall Grand Winner among over 40 submittals which entered the chamber’s Corporate Social Responsibility event. This year marks the 26th anniversary of the award and the first year when a Grand Winner was selected among all proposals.
The “Information and Wellbeing Centers” is an integrated initiative that works toward positively impacting the lives of farm employees and families by providing support and access to information from over thirty public and private organizations that interact with citizens daily.
The concept was developed through a diagnosis to understand the major needs that the Dole rural workforce has and how the company could assist in better fulfilling these needs. A myriad of paperwork and processes that workers and families are confronted with—and have difficulty resolving—or result in lost opportunities, were identified. Frequently, dealing with bureaucracy also results in lost time and revenue, increased expenses, long distance travel, and diminished livelihoods, particularly in rural areas that have limited public and private services.
In practical terms, the Information Centers allow Dole workers to access services for themselves or direct family members to resolve issues linked to their social benefits, residence, personal finance and much more. Those issues would be difficult or too costly to solve by themselves.
As one Dole farmworker stated, “My spouse could not receive medical attention because she did not have a formal job and did not have the resources to make contributions to the medical plan. Thanks to the intervention of the Information Center we managed to make the registration and my spouse can enjoy social security benefits.”
Dole is the first business of any kind in the country to offer this free service to its farm employees directly at the workplace. The Information and Wellbeing Center is a resource at the hands of 3,300 workers and their families, which promotes personal and family development, a sense of belonging and motivation.
“We are extremely proud to receive two awards at this prestigious social responsibility event. The designation as Grand Winner among so many fine examples of social responsibility in Costa Rica is a testament to the team effort required to conceive and build these Centers for our farm employees,” said Mr. Renieri Nuñez, Vice President of Pineapple Operations for Latin America. “There is no doubt that when efforts are focused on the person, our major company asset, results can be amazing. This started as an idea to solve paperwork problems and has turned out to be the most significant step in motivating employees at all levels in our organization and producing tangible results in the lives of our families.”
Through direct contacts with more than 39 institutions, the centers provide training on the use of digital platforms and support for information, advice, and follow-up of personal cases and procedures with the participating organizations.
Some of the achievements are reflected in the positive impact on household finances, use of time, and in the reduction of geographic, technological, educational, economic, and social gaps. Families have greater access to citizen rights, public and private benefits, services, and opportunities. By assisting its employees with this unique service, Dole has enjoyed increased commitment, reduced absenteeism, and created a very positive workplace environment.
The project by the numbers (as of August 2022):
- Information centers have now been extended to all four company pineapple farms.
- 3,978 users have been served by the centers.
- 11,552 services provided.
- 10,195 inquiries via WhatsApp.
- 6,378 interventions have been successful in obtaining results such as licenses, passports, national and residence cards, insurance, loans, opening of bank or savings accounts, and procedures on computer platforms, among others.
- At least 2,170 services have contributed to address multidimensional poverty.
- On average, 34.4% of users have used the center on more than one occasion.
- 536 workers have been trained in the management of personal procedures.
In 2020, Dole introduced its three-pillared Sustainability Framework, The Dole Way, and its ongoing commitment For Food, For Nature and For People. Just as Dole Costa Rica was a pioneer nearly 25 years ago in the development of global environmental management systems in agriculture to frame its efforts 'For Nature,' at the beginning of this decade the company once again innovates by establishing Information and Wellbeing Centers focused on its most important resource: 'For People.'
About Dole plc
Dole plc is one of the world’s largest producers and marketers of high-quality fresh fruit and fresh vegetables. Dole plc is an industry leader in many of the products it sells, as well as in nutrition education and research. For more information, please visit www.dole.com.
About The Dole Way
In April 2020, Dole Food Company announced The Dole Way, introducing its sustainability commitment and framework around People, Nature and Food. For more information, please visit www.dole.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221121005224/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
